Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by general360on Nov 03, 2021 9:29am
181 Views
Post# 34081402

RE:RE:Enters into a Cooperation Agreement

RE:RE:Enters into a Cooperation AgreementMe again! ....


"Sounds like that long-awaited (maybe mythical) revenue may actually happen."

Or not!  this news release, is it really news?  it is finally something "concrete": "is pleased to announce today that it has entered into a cooperation agreement with the Supreme Council"

there is an actual agreement!!!  but on what?!  are they part of the trial(s)? nope.
are they giving us money right now by entering into the agreement? not that i can tell!

so what is the benefit of this agreement?  only thing i can see is intangible: "support" , or "belief" in apabetalone, or whatnot.  no money now, no trial participation, etc.

another communications piece that needs to be interpreted or twisted. 

lets see what mr market says in 2min.... 

hope this blows the top off, but i'm not sure it will...lets see....


--general optimist



<< Previous
Bullboard Posts
Next >>